Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy.

MLA

Zuidmeer-Jongejan, Laurian, et al. “Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy.” International Archives of Allergy & Immunology, vol. 166, no. 1, Apr. 2015, pp. 41–51. EBSCOhost, https://doi.org/10.1159/000371657.

APA

Zuidmeer-Jongejan, L., Huber, H., Swoboda, I., Rigby, N., Versteeg, S. a., Jensen, B. M., Quaak, S., akkerdaas, J. H., Blom, L., asturias, J., Bindslev-Jensen, C., Bernardi, M. L., Clausen, M., Ferrara, R., Hauer, M., Heyse, J., Kopp, S., Kowalski, M. L., Lewandowska-Polak, anna, & Linhart, B. (2015). Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy. International Archives of Allergy & Immunology, 166(1), 41–51. https://doi.org/10.1159/000371657

Chicago

Zuidmeer-Jongejan, Laurian, Hans Huber, Ines Swoboda, Neil Rigby, Serge a. Versteeg, Bettina M. Jensen, Suzanne Quaak, et al. 2015. “Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy.” International Archives of Allergy & Immunology 166 (1): 41–51. doi:10.1159/000371657.